Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lusher

Showing results (151-160 of 177) with videos related to

Pageof 18
Sort By:
Clinical Chemistry|October 1, 1971
Automated dithionite test for rapid, inexpensive detection of hemoglobin S and non-S sickling hemoglobinopathiesR M Nalbandian, B M Nichols, F R Camp, et al.
Clinical Chemistry|October 1, 1971
Dithionite tube test--a rapid, inexpensive technique for the detection of hemoglobin S and non-S sickling hemoglobinR M Nalbandian, B M Nichols, F R Camp, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 1999
A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study GroupJ M Lusher, H R Roberts, G Davignon, et al.
Blood|August 1, 1992
Effect of age on human immunodeficiency virus type 1-induced changes in lymphocyte populations among persons with congenital clotting disorders. Transfusion Safety Study GroupM A Fletcher, J W Mosley, J Hassett, et al.
The New England Journal of Medicine|February 11, 1993
Low CD4+ counts in a study of transfusion safety. The Transfusion Safety Study GroupL M Aledort, E A Operskalski, S L Dietrich, et al.
Progress in Clinical and Biological Research|January 1, 1984
Panel discussion on the treatment of patients with factor VIII inhibitorsJ M Lusher, M E Eyster, M W Hilgartner, et al.
BMJ (Clinical Research Ed.)|January 25, 1992
Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study GroupL M Aledort, M W Hilgartner, M C Pike, et al.
Blood|November 1, 1983
Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIIIJ M Lusher, P M Blatt, J A Penner, et al.
Archives of Internal Medicine|June 1, 1989
The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experienceD B Brettler, A D Forsberg, P H Levine, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 24, 1999
Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest riskE C Thorland, J B Drost, J M Lusher, et al.
Pageof 18

Showing results (151-160 of 177) with videos related to

Sort By:
Pageof 18
Clinical Chemistry|October 1, 1971
Automated dithionite test for rapid, inexpensive detection of hemoglobin S and non-S sickling hemoglobinopathiesR M Nalbandian, B M Nichols, F R Camp, et al.
Clinical Chemistry|October 1, 1971
Dithionite tube test--a rapid, inexpensive technique for the detection of hemoglobin S and non-S sickling hemoglobinR M Nalbandian, B M Nichols, F R Camp, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 1999
A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study GroupJ M Lusher, H R Roberts, G Davignon, et al.
Blood|August 1, 1992
Effect of age on human immunodeficiency virus type 1-induced changes in lymphocyte populations among persons with congenital clotting disorders. Transfusion Safety Study GroupM A Fletcher, J W Mosley, J Hassett, et al.
The New England Journal of Medicine|February 11, 1993
Low CD4+ counts in a study of transfusion safety. The Transfusion Safety Study GroupL M Aledort, E A Operskalski, S L Dietrich, et al.
Progress in Clinical and Biological Research|January 1, 1984
Panel discussion on the treatment of patients with factor VIII inhibitorsJ M Lusher, M E Eyster, M W Hilgartner, et al.
BMJ (Clinical Research Ed.)|January 25, 1992
Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study GroupL M Aledort, M W Hilgartner, M C Pike, et al.
Blood|November 1, 1983
Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIIIJ M Lusher, P M Blatt, J A Penner, et al.
Archives of Internal Medicine|June 1, 1989
The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experienceD B Brettler, A D Forsberg, P H Levine, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 24, 1999
Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest riskE C Thorland, J B Drost, J M Lusher, et al.
Pageof 18